Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_assertion type Assertion NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_head.
- NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_provenance.
- NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_assertion evidence source_evidence_literature NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_provenance.
- NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_assertion SIO_000772 19434073 NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_provenance.
- NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_assertion wasDerivedFrom befree-20150227 NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_provenance.
- NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_assertion wasGeneratedBy ECO_0000203 NP382093.RAqZOjPVUAgOH3tRjGcUGJ13dEpvLT8dk1_jr5sJY7jDg130_provenance.